Listed

Prelude Therapeutics Inc

PRLDNasdaqCIK 1678660HealthcareFiscal year ends Dec 31

Reports and events: 115 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Prelude Therapeutics Inc, Reports and events
FiledFormWhat it isAccession number
2021-03-1608:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-013327
2021-03-0816:09 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-073187
2021-01-2916:48 ETSC 13D/AOwnership report, active investor, amended0001104659-21-009438
2021-01-2816:46 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-020863
2021-01-1417:34 ETSC 13D/AOwnership report, active investor, amended0000947871-21-000059
2021-01-0416:19 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-000986
2021-01-0416:08 ETS-1Registration statement0001193125-21-000946
2020-11-1008:00 ET10-QQuarterly reportPeriod 2020-09-300001564590-20-052747
2020-11-1007:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-20-052741
2020-11-0416:09 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-20-285568
2020-10-0517:17 ETSC 13DOwnership report, active investor0000947871-20-000772
2020-09-3017:25 ETSC 13DOwnership report, active investor0001104659-20-110491
2020-09-2106:08 ETS-1/ARegistration statement, amended0001193125-20-249549
2020-09-1611:53 ETS-1/ARegistration statement, amended0001193125-20-246920
2020-09-0416:48 ETS-1Registration statement0001193125-20-240138

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.